Clinical trial
A Multicenter Non-interventional Study To Observe The Safety And Efficacy Of Etanercept (Enbrel (Registered)) In Patients With Moderately Active Rheumatoid Arthritis In Every Day Clinical Practice In Austria
NCT01877239 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Non-interventional Study To Observe The Safety And Efficacy Of Etanercept (Enbrel (Registered)) In Patients With Moderately Active Rheumatoid Arthritis In Every Day Clinical Practice In Austria
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 10, 2012
- Completion date
- June 14, 2016
- Enrollment
- 111 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis